fluorometholone and Corneal Endothelial Cell Damage

fluorometholone has been researched along with Corneal Endothelial Cell Damage in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bishop, FM; Hofmeister, EM; Kaupp, SE; Schallhorn, SC	1
Bachmann, BO; Kruse, FE; Price, FW; Price, MO; Tourtas, T	1
Feng, MT; Price, FW; Price, MO; Scanameo, A	1

Trials

2 trial(s) available for fluorometholone and Corneal Endothelial Cell Damage

Article	Year
Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia. Journal of cataract and refractive surgery, 2013, Volume: 39, Issue:9 Topics: Adult; Alkylating Agents; Cell Count; Corneal Endothelial Cell Loss; Corneal Opacity; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Corneal; Female; Fluorometholone; Glucocorticoids; Humans; Lasers, Excimer; Male; Middle Aged; Mitomycin; Myopia; Photorefractive Keratectomy; Postoperative Complications; Prospective Studies; Refraction, Ocular; Visual Acuity; Young Adult	2013
Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty. Cornea, 2014, Volume: 33, Issue:9 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss; Descemet Stripping Endothelial Keratoplasty; Female; Fluorometholone; Fuchs' Endothelial Dystrophy; Glaucoma; Glucocorticoids; Graft Rejection; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Prednisolone; Prospective Studies	2014

Article

Year

Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.

Journal of cataract and refractive surgery, 2013, Volume: 39, Issue:9

Topics: Adult; Alkylating Agents; Cell Count; Corneal Endothelial Cell Loss; Corneal Opacity; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Corneal; Female; Fluorometholone; Glucocorticoids; Humans; Lasers, Excimer; Male; Middle Aged; Mitomycin; Myopia; Photorefractive Keratectomy; Postoperative Complications; Prospective Studies; Refraction, Ocular; Visual Acuity; Young Adult

2013

Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.

Cornea, 2014, Volume: 33, Issue:9

Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss; Descemet Stripping Endothelial Keratoplasty; Female; Fluorometholone; Fuchs' Endothelial Dystrophy; Glaucoma; Glucocorticoids; Graft Rejection; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Prednisolone; Prospective Studies

2014

Other Studies

1 other study(ies) available for fluorometholone and Corneal Endothelial Cell Damage

Article	Year
Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids. Ophthalmology, 2016, Volume: 123, Issue:6 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss; Descemet Stripping Endothelial Keratoplasty; Endothelium, Corneal; Female; Fluorometholone; Fuchs' Endothelial Dystrophy; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Longitudinal Studies; Loteprednol Etabonate; Male; Middle Aged; Ophthalmic Solutions; Prednisolone; Prospective Studies; Risk Factors; Withholding Treatment; Young Adult	2016

Article

Year

Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids.

Ophthalmology, 2016, Volume: 123, Issue:6

Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss; Descemet Stripping Endothelial Keratoplasty; Endothelium, Corneal; Female; Fluorometholone; Fuchs' Endothelial Dystrophy; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Longitudinal Studies; Loteprednol Etabonate; Male; Middle Aged; Ophthalmic Solutions; Prednisolone; Prospective Studies; Risk Factors; Withholding Treatment; Young Adult

2016